# Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM

> **NCT06496412** · NA · RECRUITING · sponsor: **Second Xiangya Hospital of Central South University** · enrollment: 40 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** fecal microbiota transplantation
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06496412
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-20
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06496412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06496412, "Safety and Efficacy of Fecal Microbiota Transplantation on Cognitive Function in T1DM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06496412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*